[1] World Health Organization. WHO Coronavirus (COVID-19) Dashboard. World Health Organization; 2022. https://covid19.who.int/. [2022-4-20].https://covid19.who.int/
[2] National Health Commission. Up to April 19th, the latest situation of COVID-19: National Health Commission; 2022. http://www.nhc.gov.cn/xcs/yqfkdt/202204/378f7fc3484e4b41bb845a0854552a6c.shtml. [2022-4-20]. (In Chinese). http://www.nhc.gov.cn/xcs/yqfkdt/202204/378f7fc3484e4b41bb845a0854552a6c.shtml
[3] National Health Commission. Transcript of the press conference of the joint prevention and control mechanism of the State Council on April 19, 2022. National Health Commission; 2022. http://www.nhc.gov.cn/xcs/fkdt/202204/71904942749945c9a460aed122484c3d.shtml. [2022-4-20]. (In Chinese). http://www.nhc.gov.cn/xcs/fkdt/202204/71904942749945c9a460aed122484c3d.shtml
[4] Wu Y, Liu J, Liu M, Liang WN. Epidemiological characteristics of SARS-CoV-2 Omicron Variant and the scientific control suggestions. http://dx.doi.org/10.16462/j.cnki.zhjbkz.2022.05.001.http://dx.doi.org/10.16462/j.cnki.zhjbkz.2022.05.001
[5] Wu Y, Liu J, Liu M, Liang WN. Epidemiologic features and containment of SARS-CoV-2 omicron variant. Chin General Pract 2022;25(1):14 − 9. http://dx.doi.org/10.12114/j.issn.1007-9572.2021.00.348CrossRef
[6] Smith DJ, Hakim AJ, Leung GM, Xu WB, Schluter WW, Novak RT, et al. COVID-19 mortality and vaccine coverage — Hong Kong special administrative region, China, January 6, 2022–March 21, 2022. China CDC Wkly 2022;71(15):545 − 8. http://dx.doi.org/10.15585/mmwr.mm7115e1CrossRef
[7] Centre for Health Protection of the Department of Health and the Hospital Authority. The Statistics on 5th Wave of COVID-19 in Hong Kong. Centre for Health Protection of the Department of Health and the Hospital Authority; 2022. https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf. [2022-4-20]. (In Chinese). https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf
[8] McMenamin ME, Nealon J, Lin Y, Wong JY, Cheung JK, Lau EHY, et al. Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong. medRxiv 2022. http://dx.doi.org/10.1101/2022.03.22.22272769.http://dx.doi.org/10.1101/2022.03.22.22272769
[9] Shen ST. Improve the prevention and control measures and strengthen the treatment force. The People’s Daily. 2022 Apr 14. https://wap.peopleapp.com/article/6628510/6504148?share_token=c108dba5-8bdb-45ca-9153-006916645c70. (In Chinese).  https://wap.peopleapp.com/article/6628510/6504148?share_token=c108dba5-8bdb-45ca-9153-006916645c70
[10] Ma XW. Curb the spread of the epidemic as soon as possible and resolutely consolidate the hard won achievements in prevention and control. Study Times 2022;1774:1-4. http://paper.cntheory.com/html/2022-04/18/nw.D110000xxsb_20220418_1-A1.htm.(In Chinese). 
[11] Liu J, Liu M, Liang WN. The dynamic COVID-Zero strategy in China. China CDC Wkly 2022;4(4):74 − 5. http://dx.doi.org/10.46234/ccdcw2022.015CrossRef